Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)

Avanos Medical (AVNS) has disclosed Liabilities from Discontinued Operations for 6 consecutive years, with 52900000.0 as the latest value for Q3 2024.

  • Quarterly Liabilities from Discontinued Operations rose 2016.0% to 52900000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 52900000.0 through Sep 2024, up 2016.0% year-over-year, with the annual reading at 63700000.0 for FY2023, 797.18% up from the prior year.
  • Liabilities from Discontinued Operations hit 52900000.0 in Q3 2024 for Avanos Medical, roughly flat from 52700000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 63700000.0 in Q4 2023 to a low of 2500000.0 in Q3 2023.
  • Historically, Liabilities from Discontinued Operations has averaged 38516666.67 across 3 years, with a median of 52450000.0 in 2024.
  • Biggest five-year swings in Liabilities from Discontinued Operations: surged 797.18% in 2023 and later skyrocketed 2016.0% in 2024.
  • Year by year, Liabilities from Discontinued Operations stood at 7100000.0 in 2022, then soared by 797.18% to 63700000.0 in 2023, then decreased by 16.95% to 52900000.0 in 2024.
  • Business Quant data shows Liabilities from Discontinued Operations for AVNS at 52900000.0 in Q3 2024, 52700000.0 in Q2 2024, and 52200000.0 in Q1 2024.